from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0637/hadC

LFCtreatmentdescriptionclass of inhibitor

-0.761

Amikacinug/mL Amikacintranslation

-0.401

Cap5-10ug/mL Capreomycintranslation

0.253

Rox10-50 ug/mL Roxithromycintranslation

0.975

SM2-5 ug/mL Streptomycintranslation

-0.717

Tet5-10 ug/mL Tetracyclinetranslation

0.368

Rif0.2-5ug/mL Rifampicintranscription

0.056

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.686

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.172

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.998

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.006

Clofazimine10-13 ug/mL Clofaziminerespiration

0.280

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.367

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.234

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.857

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.437

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.449

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.897

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.452

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.534

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.753

KCN5-20 ug/mL Potassium cyaniderespiration

-0.036

NaN30.2-2 mM Sodium aziderespiration

0.677

Nigericin50 uM Nigericinrespiration

-1.015

TRC10-150 ug/mL Triclosanrespiration

-0.501

TRZ10-25 ug/mL Thioridazinerespiration

-0.853

Valinomycin0.5-10 uM Valinomycinrespiration

0.836

ZnSO42 mM ZnSO4respiration

-0.777

menadione6-10 ug/mL Menadionerespiration

0.255

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.696

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.081

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.745

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.847

NRP_1Non-replicating persistence stage 1dosRassociated

0.829

Amp0.2mg/mL AmpicillincellWall

0.346

Cephalexin20-100 ug/mL CephalexincellWall

0.761

Cerulenin0.32-5 ug/mL CerulenincellWall

1.109

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.669

EMB10-20 ug/mL EthambutolcellWall

0.424

Eta12-40 ug/mL EthionamidecellWall

1.015

INH0.2-0.4 ug/mL IsoniazidcellWall

0.719

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.130

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.669

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.045

BZA0.12 mg/mL BenzamidearomaticAmides

0.151

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.026

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.194

H2O24 mM hydrogen peroxideDNAdamaging

0.723

Levo10 ug/mL LevofloxacinDNAdamaging

0.459

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.173

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.836

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.098

UVUV-irradiationDNAdamaging

-1.021

ARP41-4 ug/mL Antitubercular compound ARP4?

0.606

Antimycin12.5-50 ug/mL Antimycin A?

0.719

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.600

PA_110-50 ug/mL Antitubercular compound PA-1?

0.283

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.640

PA8240.2-2 ug/mL PA-824?

-0.712

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.358

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.458

Verapamil50 uM Verapamil?

0.695

mercaptoethanol2 mM 2-Mercaptoethanol?

0.976

methoxatin10-20 ug/mL Methoxatin?